Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Illumina    ILMN

ILLUMINA (ILMN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Illumina : Files New Patent Infringement Suit Against Premaitha Health plc

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/07/2017 | 03:04pm CET

Illumina, Inc. (NASDAQ:ILMN) announced today that the company has filed a new patent infringement suit against Premaitha Health plc in the High Court of Justice, Chancery Division, Patents Court in the United Kingdom. Illumina is seeking all available remedies, including damages and injunctive relief.

The new suit accuses Premaitha’s IONA® Test of infringing European Patent (UK) 1 524 321 B2 titled, “Non-invasive Detection of Fetal Genetic Traits,” which is exclusively licensed to Illumina from Sequenom, Inc.

Illumina and its wholly owned subsidiary, Verinata Health, Inc., previously filed suits in the UK against Premaitha accusing its Iona test of infringing European Patent (UK) 0 994 963 B2, European Patent (UK) 1 981 995 B1, European Patent (UK) 2 183 693 B1, European Patent (UK) 2 385 143 B1 and European Patent (UK) 2 514 842 B1. Those suits remain pending.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.


© Business Wire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ILLUMINA
01/19 ILLUMINA : Launches iSeq 100 Sequencing System
01/19 THERMO FISHER SCIENTIFIC : and Illumina Sign Agreement to Provide Research Marke..
01/16 ILLUMINA : to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on ..
01/15 LUNA DNA : Announces Dawn Barry, former Illumina VP, as President
01/11 ILLUMINA : Patent Issued for Method for Nucleotide Detection (USPTO 9856529)
01/11 ILLUMINA, INC. (NASDAQ : ILMN) Files An 8-K Results of Operations and Financial ..
01/11 ILLUMINA INC : Results of Operations and Financial Condition, Financial Statemen..
01/09 ILLUMINA : Thermo Fisher Scientific and Illumina Sign Agreement to Provide Resea..
01/09 ILLUMINA : Launches iSeq 100 Sequencing System
01/04 ILLUMINA : and KingMed Diagnostics Partner to Develop Next-Generation Sequencing..
More news
News from SeekingAlpha
01/21 An 'All-Weather' Income Portfolio For Financial Independence
01/17 HEALTHCARE : The 'Week That Was' Was Good
01/17 ILLUMINA : Great Company, Expensive Stock
01/11 YOUR DAILY PHARMA SCOOP : Roche Highlights Pipeline, GenSight Gets Nod To Start ..
01/09 PacBio's Library Preparation Issues Announced At A Tough Time
Financials ($)
Sales 2017 2 727 M
EBIT 2017 658 M
Net income 2017 817 M
Finance 2017 809 M
Yield 2017 -
P/E ratio 2017 43,72
P/E ratio 2018 58,34
EV / Sales 2017 12,7x
EV / Sales 2018 11,0x
Capitalization 35 469 M
Chart ILLUMINA
Duration : Period :
Illumina Technical Analysis Chart | ILMN | US4523271090 | 4-Traders
Technical analysis trends ILLUMINA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 240 $
Spread / Average Target -1,0%
EPS Revisions
Managers
NameTitle
Francis A. deSouza President, Chief Executive Officer & Director
Jay T. Flatley Executive Chairman
Robert P. Ragusa Senior Vice President-Global Quality & Operations
Sam A. Samad Chief Financial Officer & Senior Vice President
Mostafa Ronaghi Chief Technology Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
ILLUMINA12.22%35 469
INTUITIVE SURGICAL18.91%0
THERMO FISHER SCIENTIFIC12.44%0
BOSTON SCIENTIFIC CORPORATION11.54%0
DANAHER8.34%0
EDWARDS LIFESCIENCES9.94%0